MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
OpGen Long Term Debt Current 2011-2026 | OPGN
Annual Long Term Debt Current OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 K | 148 K | 378 K | 460 K | 964 K | 1.02 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.02 M | 148 K | 523 K |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 24.83 | 0.4 % | $ 690 M | USA |
 |
Danaher Corporation
DHR
|
199 M | $ 191.01 | -0.56 % | $ 136 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.91 | -3.11 % | $ 481 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 93.3 | 4.06 % | $ 11.7 B | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 17.67 | -0.84 % | $ 942 M | USA |
 |
DexCom
DXCM
|
21.6 M | $ 63.11 | -0.16 % | $ 24.6 B | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 107.16 | -2.24 % | $ 8.84 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
93 M | $ 170.62 | -0.01 % | $ 29.3 B | USA |
 |
Co-Diagnostics
CODX
|
662 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 269.17 | -1.93 % | $ 22.4 B | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 78.08 | 2.89 % | $ 5.27 B | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 508.52 | 2.52 % | $ 14.7 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 169.54 | 0.78 % | $ 8.4 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K |  Israel |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 270.0 | 0.27 % | $ 26.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.74 | 1.5 % | $ 439 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.06 | 0.5 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.98 | 4.39 % | $ 2.16 B | USA |
 |
Natera
NTRA
|
7.64 M | $ 209.27 | 2.15 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
719 K | $ 14.53 | -5.4 % | $ 1.88 B | USA |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 1.44 | 1.41 % | $ 432 M | USA |
 |
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | USA |
 |
Precipio
PRPO
|
410 K | $ 28.5 | 9.7 % | $ 45.7 M | USA |
 |
Personalis
PSNL
|
7.7 M | $ 6.17 | -6.23 % | $ 366 M | USA |
 |
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Illumina
ILMN
|
79 M | $ 126.44 | -1.02 % | $ 20.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
41 K | $ 2.69 | 3.86 % | $ 87.3 K | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.16 | -0.46 % | $ 4.96 M | USA |
 |
BioNano Genomics
BNGO
|
697 K | $ 1.17 | 1.74 % | $ 6.37 M | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 2.0 | 1.27 % | $ 8.85 M | USA |